Clinical Trial Update: Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial compared sitagliptin to a dose increase of insulin in patients with type 2 diabetes on insulin therapy, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes | Phase 4 | Status: COMPLETED